Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for GERD Symptoms and Acid Exposure
NCT00564590Phase 2Unknown
- Sponsor
- Rabin Medical Center
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melatonin in gastroesophageal reflux disease (GERD), sponsored by Rabin Medical Center. Status: unknown.
02
Drugs
melatonin
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00564590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00564590.